Ingrediente activo Erdafitinib (inhibidor de tirosina quinasa FGFR) Forma de dosificación Comprimidos recubiertos de película para administración oral Concentraciones disponibles 3 mg (amarillo, redondo biconvexo, en relieve "3" / "EF"), 4 mg (naranja, redondo biconvexo, en re
HONG KONG DENGYUE PHARMACEUTICAL CO., LIMITED [2026-01-23 14:08:30 ]
BALVERSA® (erdafitinib) is an oral, once-daily kinase inhibitor targeting fibroblast growth factor receptors (FGFR1, FGFR2, FGFR3, and FGFR4). It is indicated for the treatment of adult patients with locally advanced or metastatic urothelial carcinoma (mUC) with susceptible FGFR
HONG KONG DENGYUE PHARMACEUTICAL CO., LIMITED [2026-01-16 09:22:47 ]